Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis
Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis作者机构:Department of Infectious Disease First Affiliated Hospital Medical School of Zhejiang University Zhejiang Province China.
出 版 物:《World Journal of Gastroenterology》 (世界胃肠病学杂志(英文版))
年 卷 期:2005年第11卷第46期
页 面:7364-7367页
核心收录:
学科分类:1007[医学-药学(可授医学、理学学位)] 100705[医学-微生物与生化药学] 1001[医学-基础医学(可授医学、理学学位)] 100103[医学-病原生物学] 10[医学]
基 金:Supported by a Health Foundation of Zhejiang Province No.2004C083 2004B068
主 题:Platelet-activating factor Malondialdehyde Endotoxin rHPLC Viral hepatitis
摘 要:AIM: To detect the plateletoactivating factor (PAF) and the plasma or serum levels of tumor necrosis factoroa (TNF-α) malondialdehyde (MDA), endotoxin (ET) and to discuss their significance in various types of viral hepatitis. METHODS: PAF, TNF-α, MDA, and ET levels in 60 controls, 16 cases of acute viral hepatitis, 71 cases of chronic viral hepatitis, 19 cases of severe viral hepatitis were detected by reverse phase high-performance liquid chromatography (rHPLC), bio-assay, ELISA, thiobarbituric acid (TBA), and limulus lysate test (LLT), respectively. RESULTS: The rHPLC was more sensitive and specific than bio-assay (r = 0.912, P〈0.01). The plasma levels of PAF, TNF-α, MDA, and ET in patients with viral hepatitis were higher than those in controls (P〈0.01). CONCLUSION: rHPLC is more reliable and accurate for the detection of PAF.